Search by Drug Name or NDC

    NDC 24208-0505-05 Levobunolol Hydrochloride 5 mg/mL Details

    Levobunolol Hydrochloride 5 mg/mL

    Levobunolol Hydrochloride is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is LEVOBUNOLOL HYDROCHLORIDE.

    Product Information

    NDC 24208-0505
    Product ID 24208-505_824dc29c-3ab9-4e52-9a4d-82ca578ee3b0
    Associated GPIs 86250020102005
    GCN Sequence Number 007858
    GCN Sequence Number Description levobunolol HCl DROPS 0.5 % OPHTHALMIC
    HIC3 Q6G
    HIC3 Description MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS
    GCN 33310
    HICL Sequence Number 003459
    HICL Sequence Number Description LEVOBUNOLOL HCL
    Brand/Generic Generic
    Proprietary Name Levobunolol Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levobunolol Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name LEVOBUNOLOL HYDROCHLORIDE
    Labeler Name Bausch & Lomb Incorporated
    Pharmaceutical Class Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074326
    Listing Certified Through 2024-12-31

    Package

    NDC 24208-0505-05 (24208050505)

    NDC Package Code 24208-505-05
    Billing NDC 24208050505
    Package 1 BOTTLE, DROPPER in 1 CARTON (24208-505-05) / 5 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 1994-03-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.21875
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description LEVOBUNOLOL 0.5% EYE DROPS
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis